ConductScience.org, home

Trial · NCT04431778

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

NCT04431778, Phase 2, Unknown, University Hospital, Clermont-Ferrand

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain. Trials, record NCT04431778. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04431778

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain
NCT number
NCT04431778
Status
Unknown
Phases
Phase 2
Enrollment
64 participants, estimated
Lead sponsor
University Hospital, Clermont-Ferrand
Conditions
Peripheral Neuropathic Pain
Interventions
Ethosuximide, Placebo
First posted
2020-06-16
Last updated
2023-01-06

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNeuropathic pain intensityDay 0Variation in pain intensity (NRS, Numerical Rating Scale 0-10) averaged over the 7 days prior to the start of treatment (D0) and over the last 7 days of treatment (12 weeks).
PrimaryNeuropathic pain intensityDay 84Variation in pain intensity (NRS, Numerical Rating Scale 0-10) averaged over the 7 days prior to the start of treatment (D0) and over the last 7 days of treatment (12 weeks).
SecondaryPatient's Global Impression of Change (PGIC scale)Day 0, Day 28, Day 56, Day 84Assessment of the patient's feelings about the effectiveness of the treatment.
SecondaryHealth related quality of lifeDay 0, Day 28, Day 56, Day 84Assessment of the patient's quality of life with EQ-5D-3L questionnaire
SecondaryQuantitative sensory testing (QST)Day 0, Day 28, Day 56, Day 84Assessment of mechanical sensitivity using the von Frey test (static allodynia) and the brush test (dynamic allodynia).
Secondaryadverse eventThroughout the studyAssessment of the tolerability of the treatment by patients and clinicians

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04431778

GET https://conductscience.org/api/trials/v1/NCT04431778/registered